We evaluated the diagnostic value of antibody to Blastomyces dermatitidis A precipitin arcs for identifying B The immunoidentification by exoantigens of such mycelial-form fungal pathogens as Coccidioides immitis, Exophiala jeanselmei, Histoplasma capsulatum, Paracoccidioides brasiliensis, and Wangiella dermatitidis (15; L. Kaufman, P. Standard, and A. A. Padhye, Mycopathologia, in press) is proving to be a valuable diagnostic procedure. Reports to date, although preliminary, indicate that Blastomyces dermatitidis mycelial-form cultures may also be rapidly and accurately identified by the exoantigen technique.
Manych and Sourek (12) were the first to use agar gel precipitation to identify B. dermatitidis cultures. Identification was based on the formation of a tube precipitin band after incubating a culture with B. dermatitidis rabbit antiserum for 4 weeks. The means of determining the specificity of the precipitate were not described. In 1977, Rippon et al. (13) , using washings from a slant culture and sera from a patient with blastomycosis and a rabbit with B. dermatitidis antibodies, reported that reverse immunodiffusion may be used to identify fungus cultures. In 1973 (5), a specific precipitin, designated A, was found in patients with blastomycosis. Later, Kaufman and Standard (7) used sera containing antibody to A antigen to show the apparent specific production of exoantigen A in some B.
dermatitidis isolates. The present study evaluated more extensively the specificity and sensitivity of the B. dermatitidis exoantigen test with a large number of B. dermatitidis isolates obtained from various parts of the world, as well as with many morphologically related hyphomycetous fungi.
MATERIALS AND METHODS Antisera and antigens. The antigens used to produce antisera were prepared from three yeast-form cultures of B. dermatitidis (strains X-79, B-832, and B-3015) that had been grown in brain heart infusion broth (Difco Laboratories). The broth cultures were shaken for 1 week at 150 to 160 rpm during incubation at 37°C. The cultures were killed by adding merthiolate to a concentration of 1:5,000. After appropriate sterility checks, the yeast cells were removed by centrifugation, and the supernatants were concentrated 10 times and retained. The yeast cells were washed twice in merthiolated saline and adjusted to a turbidity equivalent to a no. 3 McFarland nephelometric standard for immunization.
The standardized yeast suspensions, in doses of 1, 2, and 2 ml, respectively, were injected intravenously into rabbits on the first, second, and third days of the week for 2 consecutive weeks. Each rabbit was bled 1 week after the final injection, and the serum titers were determined against the homologous 10-timesconcentrated supernatant antigens (5) . Rabbits whose sera failed to give well-defined precipitin bands re- ceived an additional weekly series of injections until well-defined precipitates developed. Control antisera against the A antigen were also prepared in rabbits with newly isolated immunoelectrophoretic precipitin arcs as a vaccine by the method of Green et al. (3, 4) . The arcs were produced from the concentrated B. dermatitidis culture supernatants and A arc antiserum.
Adsorption procedure. Antigens for adsorption consisted of whole cells grown and harvested in the same manner as for vaccine production, but the cells were washed and suspended in phosphate-buffered saline (pH 7.2) that contained merthiolate (1:10,000). Antisera were adsorbed with half volumes of packed cells at 37°C in a water bath for 2 h. Adsorptions were repeated until precipitins to the adsorbing strains had been eliminated.
Cultures studied. B. dermatitidis isolates, including 87 from the United States, 12 from Africa, and 1 each from Canada, India, and Israel (total, 102), were examined. Data for the African isolates are given in Exoantigen tests. Culture extracts were prepared by the slant extraction method described by Kaufman and Standard (6) . Extracts from 2-to 3-week-old cultures believed to be B. dermatitidis were concentrated 50 times with an Amicon Minicon B-15 Macrosolute concentrator. Using the microimmunodiffusion procedure and rabbit anti-B. dermatitidis serum, we tested the concentrated extracts in parallel with control B. dermatitidis A antigen. The antiserum was placed in the central well and incubated for 1 h at 25°C. Reference antigens were then placed in the upper and lower wells of each pattern, and the unknown antigens were placed in duplicate in the lateral wells. Each plate was incubated in a moist chamber at 25°C for 24 h. Studies in our laboratory showed that the results obtained with these incubation conditions were similar to those obtained for plates incubated at 37°C for 48 h, as reported earlier (7).
RESULTS
Isolates of B. dermatitidis obtained from the United States and other countries were tested with antiserum to B. dermatitidis A arcs for their ability to produce the A exoantigen ( Table 2 ). All 88 North American isolates, as well as the Indian (8) and Israeli (9) isolates, produced the A antigen. Of the 12 African isolates, only one, strain B-3016 from Algeria (11), produced the A antigen; six produced an antigen unrelated to A.
The colonies of the Algerian (strain B-3016), Although the anti-B. dermatitidis A serum was produced in rabbits against the immunoelectrophoretic A arcs, it was not specific and contained precipitins other than A. Reactions to at least one of these precipitins occurred with the antigen extracts from many of the fungi studied (Table 2) .
Antisera to the intact yeast-form cells of one North American (strain X-79) and two African (strains B-832 and B-3015) isolates of B. dermatitidis were produced in rabbits. These antisera were tested for precipitin reactivity before and after adsorption with yeast cells of the homologous and heterologous B. dermatitidis isolates. The results of these studies were compared with those obtained with the unadsorbed and similarly adsorbed rabbit anti-B. dermatitidis A arc serum (Table 3) . The reactions noted with the antigens of and the antiserum to the African isolate B-832 were identical to those noted with the antigens of and the antiserum to the African isolate B-3015.
The non-African isolates reacted with the unadsorbed B. dermatitidis A arc antiserum to form an A precipitate. Similar studies with the unadsorbed B. dermatitidis A arc antiserum indicated that, except for isolate B-3016, the African isolates lacked the A antigen (Fig. 1,  Table 2 ). However, studies with the unadsorbed antisera to the North American and African isolates showed that they reacted with extracts of all the African and North American isolates used in this study, suggesting that these isolates share at least one antigen unrelated to the A antigen (Fig. 1, Table 2 and 3) .
The extracts of all of the North American isolates produced an A precipitate and another unique precipitate with the unadsorbed antiserum to North American B. dermatitidis X-79. The extracts from all of the African isolates showed a single common band that was identical to the second band that noted with the extract from the North American isolate (Fig. 1) . The extracts of both the African and North American isolates reacted with unadsorbed antisera to the African isolates, producing a single band that was apparently identical to the second band described above. This band was not apparent with extracts from any of the heterologous fungi studied (Table 2) .
Adsorbing the B. dermatitidis A arc antiserum with the antigens of African isolates B-832 and B-3015 had no effect on the A precipitin. Adsorbing the antiserum to North American isolate X-79 with cells of either of the two African isolates yielded an antiserum with the A pattern of reactivity. However, this adsorption eliminated the second precipitin common to the African isolates. Adsorbing antisera to the B. dermatitidis A arcs and to the African and North American B. dermatitidis isolates with the antigens of North American isolate X-79 rendered all of the antisera negative for precipitins.
DISCUSSION
Studies with antigen extracts of B. dermatitidis isolates from North America, India, and Israel showed that the isolates were homogeneous for production of the specific A antigen. These isolates were readily and accurately identified by the exoantigen test. In contrast, our studies with the African isolates indicated that they were antigenically heterologous and devoid of the A antigen, with the exception of isolate B-3016. The B. dermatitidis A arc antiserum could not be used to identify such isolates because it gave false-negative results. We discovered a second antigen, designated K, that was apparently common to all of the B. dermatitidis isolates studied but, like the A antigen, was absent from the heterologous fungi. Our studies suggested that the K antigen is unrelated to the previously described B. dermatitidis antigens (4, 5) . The K antigen is currently under extensive study and will be described in detail in a later publication.
Cross-adsorption studies with antisera to the North American isolate X-79 and two African isolates (B-832 and B-3015) showed the existence of serotypes among the B. dermatitidis isolates (Table 3 ). These findings confirmed the occurrence of two B. dermatitidis serotypes. These were first suggested by the immunofluorescence studies done by Sudman and Kaplan (16) . The North American isolates were for the most part antigenically more complex than the African isolates that we studied. In addition to the specific A antigen, they shared at least one other unique antigen with the African isolates. Whether the use of antibody to the latter antigen will permit the immunoidentification of all B. dermatitidis isolates has yet to be determined. When the African isolates were paired with the tester strains of Ajellomyces dermatitidis, none was stimulated. Similar observations on the incompatibility of African isolates with Ajellomyces dermatitidis were reported by KwonChung (10). Our 11 incompatible African isolates with atypical morphological and genetic features all lacked antigen A. Just as two varieties of H. capsulatum (H. capsulatum var. capsulatum, H. capsulatum var. duboisii) exist in Africa, it appears that Africa also harbors at least two varieties of B. dermatitidis.
Our findings indicate that at least two serotypes of B. dermatitidis occur. Serotype 1 has specific antigens A and K. Of the two specific antigens, serotype 2 has only K. Currently, B. dermatitidis serotype 2 is only known to occur in Africa. In contrast, serotype 1 isolates have been found in Canada, the United States, Israel, India and Algeria. Studies continue in our laboratory to compare and determine the value of the two apparently specific B. dermatitidis antigens for the immunoidentification of isolates of B. dermatitidis and for the serodiagnosis of blastomycosis.
